Predictors for response to chemotherapy and survival in locally advanced breast cancer. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text ...
Neoadjuvant cisplatin-based chemotherapy plus chemoradiotherapy offers a safe, effective bladder-sparing approach with promising long-term outcomes in nonmetastatic MIBC. Median disease-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback